Adjuvant chemotherapy could benefit early-stage ER/PR positive mucinous breast cancer: A SEER-based analysis

Adjuvant chemotherapy could benefit early-stage ER/PR positive mucinous breast cancer: A SEER-based analysis

Purpose: The aim of this study was to explore the value of adjuvant chemotherapy in patients with early-stage ER/PR-positive mucinous carcinoma. Methods: We identified early-stage ER/PR-positive mucinous carcinoma patients in the Surveillance, Epidemiology, and End Results (SEER) database. We used p...

Full description

Bibliographic Details
Main Authors: Hong-Fei Gao, Wei-Ping Li, Teng Zhu, Ci-Qiu Yang, Mei Yang, Liu-Lu Zhang, Fei Ji, Min-Yi Cheng, Jie-Qing Li, Kun Wang
Format: Article
Language:English
Published: Elsevier 2020-12-01
Series:Breast
Subjects:
Mucinous adenocarcinomas
Breast cancer
Surveillance epidemiology
And end results (SEER)
Overall survival
Adjuvant chemotherapy
Online Access:http://www.sciencedirect.com/science/article/pii/S0960977620301806

Internet

http://www.sciencedirect.com/science/article/pii/S0960977620301806

Similar Items